The incidence of cancer, a second leading cause of death globally, continues to rise steadily, and could reach 28.4 million cases by 2040, if no action is taken.
Prostate cancer, the second most common cancer in men globally following lung cancer, accounted for 1,414,259 new cases and led to 375,304 deaths in 2022.
Chemotherapy and surgery remain the major treatments however, they are associated with side effects.
In this study, the anticancer potentials of ten (10) isoflavonoids from
